AVAHO

FDA OKs sacituzumab govitecan for HR+ metastatic breast cancer

February 6, 2023

Race and geography tied to breast cancer care delays

February 6, 2023

Despite limits, COVID vaccines protect CLL patients

February 6, 2023

Black patients less likely to receive opioids for advanced cancer

February 3, 2023

Oncology

Loneliness risk elevated among young cancer survivors

February 3, 2023

Difficulty fitting family into career: Female oncologists

January 31, 2023

Oncology

Biden to end COVID emergencies in May

January 31, 2023

New cancer data spark outcry from patient advocates

January 30, 2023

FDA approves pirtobrutinib for r/r mantle cell lymphoma

January 30, 2023

Canadian guidance recommends reducing alcohol consumption

January 25, 2023

Mastocytosis: Rare, underdiagnosed, potentially fatal

January 24, 2023

Mixed Topics

Adding venetoclax improves ibrutinib outcomes in CLL

January 23, 2023

People with cancer should be wary of taking dietary supplements

January 23, 2023

Tucatinib plus trastuzumab approved for HER2+ colorectal cancer

January 23, 2023

Oncology

Off their pricey CML meds, many thrive

January 20, 2023